Common Stock, Value, Issued of Bionik Laboratories Corp. from 31 Dec 2010 to 31 Mar 2023

Taxonomy & unit: us-gaap: USD
Description: Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary: Bionik Laboratories Corp. quarterly Common Stock, Value, Issued in USD history and change rate from 31 Dec 2010 to 31 Mar 2023.
Bionik Laboratories Corp. Common Stock, Value, Issued for the quarter ending 31 Mar 2023 was $6,989, a 1.6% increase year-over-year.
Source SEC data: View on sec.gov

Common Stock, Value, Issued, Quarterly (USD)

Common Stock, Value, Issued, YoY Quarterly Change (%)

Bionik Laboratories Corp. Quarterly Common Stock, Value, Issued (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2023	$6,989	+$110	+1.6%	31 Mar 2023	10-K	21 Jun 2023	2023	FY
Q4 2022	$6,879	+$976	+17%	31 Dec 2022	10-Q	08 Feb 2023	2023	Q3
Q3 2022	$6,879	+$976	+17%	30 Sep 2022	10-Q	09 Nov 2022	2023	Q2
Q2 2022	$6,879	+$1,177	+21%	30 Jun 2022	10-Q	10 Aug 2022	2022	Q1
Q1 2022	$6,879	+$1,177	+21%	31 Mar 2022	10-K	21 Jun 2023	2023	FY
Q4 2021	$5,903	+$777	+15%	31 Dec 2021	10-Q	09 Feb 2022	2022	Q3
Q3 2021	$5,903	+$777	+15%	30 Sep 2021	10-Q	10 Nov 2021	2022	Q2
Q2 2021	$5,702	+$576	+11%	30 Jun 2021	10-Q	12 Aug 2021	2022	Q1
Q1 2021	$5,702	+$576	+11%	31 Mar 2021	10-K	09 Jun 2022	2022	FY
Q4 2020	$5,126	$0	0%	31 Dec 2020	10-Q	11 Feb 2021	2020	Q3
Q3 2020	$5,126	$0	0%	30 Sep 2020	10-Q	12 Nov 2020	2020	Q2
Q2 2020	$5,126	+$1,268	+33%	30 Jun 2020	10-Q	12 Aug 2020	2020	Q1
Q1 2020	$5,126	+$1,268	+33%	31 Mar 2020	10-K	24 Jun 2021	2021	FY
Q4 2019	$5,126	+$2,515	+96%	31 Dec 2019	10-Q	14 Feb 2020	2019	Q3
Q3 2019	$5,126	+$2,515	+96%	30 Sep 2019	10-Q	14 Nov 2019	2019	Q2
Q2 2019	$3,858	-$285,287	-99%	30 Jun 2019	10-Q	12 Aug 2019	2019	Q1
Q1 2019	$3,858	+$2,194	+132%	31 Mar 2019	10-K	29 Jun 2020	2020	FY
Q4 2018	$2,611	-$99,183	-97%	31 Dec 2018	10-Q	11 Feb 2019	2019	Q3
Q3 2018	$2,611	-$99,183	-97%	30 Sep 2018	10-Q	13 Nov 2018	2019	Q2
Q2 2018	$289,145	+$187,351	+184%	30 Jun 2018	10-Q	14 Aug 2018	2019	Q1
Q1 2018	$1,664	-$95,130	-98%	31 Mar 2018	10-K	01 Jul 2019	2019	FY
Q4 2017	$101,794	+$5,432	+5.6%	31 Dec 2017	10-Q	13 Feb 2018	2018	Q3
Q3 2017	$101,794	+$5,432	+5.6%	30 Sep 2017	10-Q	13 Nov 2017	2018	Q2
Q2 2017	$101,794	+$16,742	+20%	30 Jun 2017	10-Q	14 Aug 2017	2018	Q1
Q1 2017	$96,794	+$24,203	+33%	31 Mar 2017	10-K	27 Jun 2018	2018	FY
Q4 2016	$96,362	+$23,934	+33%	31 Dec 2016	10-Q	14 Feb 2017	2017	Q3
Q3 2016	$96,362	+$23,954	+33%	30 Sep 2016	10-Q	14 Nov 2016	2017	Q2
Q2 2016	$85,052	+$12,644	+17%	30 Jun 2016	10-Q	15 Aug 2016	2017	Q1
Q1 2016	$72,591	+$6,751	+10%	31 Mar 2016	8-K	21 Dec 2017
Q4 2015	$72,428	+$22,691	+46%	31 Dec 2015	10-KT	30 Jun 2016	2016	FY
Q3 2015	$72,408			30 Sep 2015	10-Q	17 Mar 2016	2015	Q3
Q2 2015	$72,408			30 Jun 2015	10-Q	17 Mar 2016	2015	Q2
Q1 2015	$65,840	-$1,592,745	-96%	31 Mar 2015	8-K	21 Dec 2017
Q4 2014	$49,737			31 Dec 2014	10-KT	30 Jun 2016	2016	FY
Q1 2014	$1,658,585	+$1,653,476	+32364%	31 Mar 2014	10-KT	27 May 2015	2014	FY
Q1 2013	$5,109	+$120	+2.4%	31 Mar 2013	10-Q	15 May 2013	2013	Q1
Q4 2012	$5,109	+$120	+2.4%	31 Dec 2012	10-Q	15 May 2013	2013	Q1
Q2 2012	$4,989			30 Jun 2012	10-Q	07 Aug 2012	2012	FY
Q1 2012	$4,989			31 Mar 2012	10-Q	15 May 2012	2012	Q1
Q4 2011	$4,989	+$89	+1.8%	31 Dec 2011	10-Q	15 May 2012	2012	Q1
Q3 2011	$4,900			30 Sep 2011	10-Q	21 Nov 2011	2011	Q3
Q4 2010	$4,900			31 Dec 2010	10-K	11 Apr 2012	2011	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.